These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5635231)

  • 41. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Hemorrhagic Telangiectasia.
    Donato M; Pimentel J; Cabral R; Escada P
    Acta Med Port; 2018 Jan; 31(1):63-66. PubMed ID: 29573771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hereditary haemorrhagic telangiectasia and oral contraceptives.
    Blackburn EK
    Lancet; 1970 Mar; 1(7647):616. PubMed ID: 4190565
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.
    Simonds J; Miller F; Mandel J; Davidson TM
    Laryngoscope; 2009 May; 119(5):988-92. PubMed ID: 19194865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [61 SEFH Congress; Outstanding Clinical Cases (second part)].
    Jefe E
    Farm Hosp; 2017 Sep; 41(5):651-658. PubMed ID: 28847261
    [No Abstract]   [Full Text] [Related]  

  • 47. Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management.
    Chin CJ; Rotenberg BW; Witterick IJ
    J Otolaryngol Head Neck Surg; 2016 Jan; 45():3. PubMed ID: 26754744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term experience with intranasal bevacizumab therapy.
    Steineger J; Osnes T; Heimdal K; Dheyauldeen S
    Laryngoscope; 2018 Oct; 128(10):2237-2244. PubMed ID: 29469958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
    Joshi H; Woodworth BA; Carney AS
    J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hereditary hemorrhagic telangiectasia: a rare cause of severe anemia.
    dos Santos JW; Dalcin TC; Neves KR; Mann KC; Pretto GL; Bertolazi AN
    J Bras Pneumol; 2007; 33(1):109-12. PubMed ID: 17568877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A natural obturator in hereditary haemorrhagic telangiectasia.
    Soni-Jaiswal A; Woolford TJ
    J Laryngol Otol; 2009 Jun; 123(6):695-6. PubMed ID: 19275781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The management of severe recurrent epistaxis due to hereditary hemorrhagic telangiectasia using regional facial cutaneous flaps.
    Strauss M; Zohar Y; Laurian N
    J Laryngol Otol; 1985 Apr; 99(4):373-7. PubMed ID: 4009036
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
    Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
    Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Endoscopic intranasal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia].
    He MQ; Liu YQ; Xu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 43(9):703-4. PubMed ID: 19035267
    [No Abstract]   [Full Text] [Related]  

  • 55. Epistaxis due to hereditary hemorrhagic telangiectasia.
    Zohar Y; Strauss M
    Laryngoscope; 1995 Apr; 105(4 Pt 1):445-6. PubMed ID: 7794350
    [No Abstract]   [Full Text] [Related]  

  • 56. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
    Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
    Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Avastin and diode laser: a combined modality in managing epistaxis in hereditary hemorrhagic telangiectasia.
    Marglani OA; Bawazeer NA; Abu Suliman OA
    Am J Otolaryngol; 2013; 34(5):603-5. PubMed ID: 23541684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Osler--Rendu Disease: an example of a family clustering in a genetic disorder].
    Mitu F; Lovin S; Rusu C; Mitu M; Georgescu T; Pandele GI; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):820-4. PubMed ID: 14974237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.